Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4580-4585

  Anderson Jr , George W ^a   Leary, Sophie E C ^b   Williamson, E Diane ^b   Titball, Richard W ^b   Welkos, Susan L ^a   Worsham, Patricia L ^a   Friedlander, Arthur M ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL VIRULENCE; CELL PROTECTION; CONTROLLED STUDY; ESCHERICHIA COLI; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; STRAIN DIFFERENCE; YERSINIA PESTIS;

EID: 10244256319     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4580-4585.1996     Document Type: Article

References (48)

1. Allison, A. C., and N. E. Byars. 1986. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J. Immunol. Methods 95:157-168.
2. Anderson, G. W., Jr., P. L. Worsham, C. R. Bolt, G. P. Andrews, S. L. Welkos, A. M. Friedlander, and J. P. Burans. Passive immunization with monoclonal antibodies against the F1 antigen of Yersinia pestis protects mice from fatal bubonic and pneumonic plague. Submitted for publication.
3. Andrews, G. P. Unpublished data.
4. Andrews, G. P., D. G. Heath, G. W. Anderson, Jr., S. L. Welkos, and A. M. Friedlander. 1996. Fraction 1 capsular antigen (F1) purification from Yersinia peslis CO92 and an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:2180-2187.
5. Ball, D. J., G. Argentieri, R. Krause, M. Lipinski, R. L. Robison, R. E. Stoll, and G. E. Visscher. 1991. Evaluation of a microchip implant system used for animal identification in rats. Lab. Anim. Sci. 41:185-186.
6. Bartelloni, P. J., J. D. Marshall, Jr., and D. C. Cavanaugh. 1973. Clinical and serological responses to plague vaccine U.S.P. Mil. Med. 138:720-722.
7. Brubaker, R. R., A. K. Sample, D. Z. Yu, R. J. Zahorchak, P. C. Hu, and J. M. Fowler. 1987. Proteolysis of V antigen from Yersinia pestis. Microb. Pathog. 2:49-62.
8. Burrows, T. W. 1957. Virulence of Pasteurella pestis. Nature (London) 179:1246-1247.
9. Burrows, T. W., and G. A. Bacon. 1958. The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis. Brit. J. Exp. Pathol. 39:278-291.
10. Cavanaugh, D. C., B. L. Elisberg, C. H. Llewelyn, J. D. Marshall, Jr., J. H. Rust, Jr., J. E. Williams, and K. F. Meyer. 1974. Plague immunization. V. Indirect evidence for the efficacy of plague vaccine. J. Infect. Dis. 129 (Suppl.):S37-S40.
11. Chen, T. H., L. E. Foster, and K. F. Meyer. 1961. Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with a vaccine prepared with killed virulent whole organisms. J. Immunol. 87:64-71.
12. Davis, K. J., D. L. Fritz, M. L. Pitt, S. L. Welkos, P. L. Worsham, and A. M. Friedlander. 1996. Pathology of experimental pneumonic plague produced by F1-positive and F1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops). Arch. Pathol. Lab. Med. 120:156-163.
13. Doll, J. M., P. S. Zeitz, P. Ettestad, A. L. Bucholtz, T. Davis, and K. Gage. 1994. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am. J. Trop. Med. Hyg. 51:109-114.
14. Drozdov, I. G., A. P. Anisimov, S. V. Samoilova, I. N. Yezhov, S. A. Yeremin, A. V. Karlyshev, V. M. Krasilnikova, and V. I. Kravchenko. 1495. Virulent non-capsulated Yersinia pestis variants constructed by insertion mutagenesis. J. Med. Microbiol. 42:264-268.
15. Drozdov, I. G., I. N. Yezhov, S. V. Samoylova, A. P. Anisimov, and A. K. Kikiforov. 1993. Evaluating biological properties of acapsular plague pathogen strain. Probl. Particularly Dangerous Infect. 71-72:154-159. (In Russian.)
16. Ehrenkranz, N., and K. F. Meyer. 1955. Studies on immunization against plague. VIII. Study of three immunizing preparations in protecting primates against pneumonic plague. J. Infect. Dis. 96:138-144.
17. Guyton, A. C. 1947. Measurement of the respiratory volumes of laboratory animals. Am. J. Physiol. 150:70-77.
18. Heath, D. G., G. W. Andersen, Jr., J. M. Mauro, S. L. Welkos, and A. M. Friedlander. Submitted for publication.
19. Henderson, D. W. 1952. An apparatus for the study of airborne infection. J. Hyg. 50:53-68.
20. Karagouni, E. E., and L. Kahjipetrou-Kouronaikis. 1990. Regulation of isotope immunoglobulin production by adjuvants in vivo. Scand. J. Immunol. 31:745-754.
21. Lawton, W. D., R. L. Erdman, and M. J. Surgalla. 1963. Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immunol. 91:179-184.
22. Leary, S. E. C., E. D. Williamson, K. F. Griffin, P. Russell, S. M. Eley, and R. W. Titball. 1995. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:2854-2858.
23. May, K. R. 1973. The Collision nebulizer, description, performance and applications. J. Aerosol Sci. 4:235-243.
24. Meyer, K. F. 1970. Effectiveness of live or killed plague vaccines in man. Bull. W. H. O. 42:653-666.
25. Meyer, K. F., and L. E. Foster. 1948. Measurement of protective serum antibodies in human volunteers inoculated with plague prophylactics. Stanford Med. Bull. 6:75-79.
26. Meyer, K. F., J. A. Hightower, and F. R. McCrumb. 1974. Plague immunization. VI. Vaccination with the fraction 1 antigen of Yersinia pestis. J. Infect. Dis. 129(Suppl.):S41-S45.
27. Motin, V. L., R. Nakajima, G. B. Smirnov, and R. R. Brubaker. 1994. Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V fusion peptide. Infect. Immun. 62:4192-4201.
28. Nakajima, R., V. L. Motin, and R. R. Brubaker. 1995. Suppression of cytokines by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect. Immun. 63:3021-3029.
29. National Research Council, Institute of Laboratory Animal Resources. 1986. Guide for the care and use of laboratory animals. U.S. Department of Health and Human Services publication no. (N1H) 86-23. U.S. Department of Health and Human Services, Bethesda, Md.
30. Pitt, M. L., P. Worsham, S. L. Welkos, and A. M. Friedlander. Unpublished data.
31. Pitt, M. L. M., J. E. Estep, S. L. Welkos, and A. Friedlander. 1994. Efficacy of killed whole-cell vaccine against a lethal aerosol challenge of plague in rodents, abstr. E-45, p. 151. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
32. Russell, P., S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg, and R. W. Titball. 1995. A comparison of plague vaccine, USP, and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13:1551-1556.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. SAS Institute, Inc. 1989. SAS/STAT user's guide, version 6. 4th ed., vol. 2. SAS Institute, Inc., Cary, N.C.
35. Sato, K., R. Nakajima, F. Hara, T. Une, and Y. Osada. 1991 Preparation of monoclonal antibody to V antigen from Yersinia pestis. Contrib. Microbiol. Immunol. 12:225-229.
36. Smith, H., and L. P. Packman. 1966. A filtered non-toxic plague vaccine which protects guinea-pigs and mice. Brit. J. Exp. Pathol. 47:25-34.
37. Smith, P. N. 1959. Pneumonic plague in mice: modification of the infection by antibody against specific components of Pasteurella pestis. J. Infect. Dis. 104:85-91.
38. 2+ in Yersinia pestis include structural genes for outer membrane proteins. Infect. Immun, 51:445-454.
39. Thomas, R. E., W. J. Simpson, L. L. Perry, and T. G. Schwan. 1992. Failure of intragastrically administered Yersinia pestis capsular antigen to protect mice against challenge with virulent plague: suppression of fraction-1 specific antibody response. Am. J. Trop. Med. Hyg. 47:92-97.
40. Une, T., and R. R. Brubaker. 1984. Roles of V antigen in promoting virulence and immunity in Yersinia. J. Immunol. 133:2226-2230.
41. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander. 1995. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13:299-305.
42. WHO Expert Committee on Plague. 1970. W.H.O. Tech. Rep. Ser. 447:16.
43. Williams, J., and D. Cavanaugh. 1974. Cryptic infection of rats with non-encapsulated variants of Yersinia pestis. Trans. R. Soc. Trop. Med Hyg. 69:171-172.
44. Williams, J. E., and D. C. Cavanaugh. 1979. Measuring the efficacy of vaccination in affording protection against plague. Bull. W. H. O. 57:309-313.
45. Williamson, E. D., S. M. Eley, K. F. Griffin, M. Green, P. Russell, S. E. C. Leary, P. C. F. Oyston, T. Easterbrook, K. M. Reddin, A. Robinson, and R. W. Titball. 1995. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12:223-230.
46. Winter, C. C., W. B. Cherry, and M. D. Moody. 1960. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull. W. H. O. 23:408-409.
47. Worsham, P., S. L. Welkos, M. L. Pitt, A. M. Friedlander, and G. W. Anderson, Jr. Unpublished data.
48. Worsham, P. L., M.-P. Stein, and S. L. Welkos. 1995. Construction of defined F1 negative mutants of virulent Yersinia pestis. Contrib. Microbiol. Immunol. 13:325-328.